University Of Notre Dame Du Lac Cerus Corp Transaction History

University Of Notre Dame Du Lac

  • $66.8 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$2.87 - $5.49 $632,011 - $1.21 Million
-220,213 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$3.84 - $4.86 $189,465 - $239,792
49,340 Added 28.88%
220,213 $929,000
Q3 2019

Nov 13, 2019
BUY
$4.86 - $6.05 $830,442 - $1.03 Million
170,873 New
170,873 $881,000

Others Institutions Holding CERS

# of Institutions
160
Shares Held
144M
Call Options Held
22.5K
Put Options Held
23.6K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $328M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track University Of Notre Dame Du Lac Portfolio

Follow University Of Notre Dame Du Lac and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of University Of Notre Dame Du Lac, based on Form 13F filings with the SEC.

News

Stay updated on University Of Notre Dame Du Lac with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email